Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
Results of the ADVANCE-MPI trial evaluated the effect of age, gender, obesity and diabetes on the effectiveness and safety of selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging.